DaVita PE Ratio 2010-2024 | DVA

Current and historical p/e ratio for DaVita (DVA) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. DaVita PE ratio as of July 22, 2024 is 15.25.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

DaVita PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-22 139.96 15.90
2024-03-31 138.05 $8.80 15.69
2023-12-31 104.76 $7.40 14.16
2023-09-30 94.53 $6.52 14.50
2023-06-30 100.47 $5.03 19.97
2023-03-31 81.11 $5.42 14.96
2022-12-31 74.67 $5.78 12.92
2022-09-30 82.77 $6.83 12.12
2022-06-30 79.96 $8.06 9.92
2022-03-31 113.11 $8.40 13.47
2021-12-31 113.76 $8.29 13.72
2021-09-30 116.26 $7.78 14.94
2021-06-30 120.43 $7.04 17.11
2020-12-31 117.40 $6.29 18.66
2020-09-30 85.65 $6.67 12.84
2020-06-30 79.14 $7.48 10.58
2020-03-31 76.06 $6.81 11.17
2019-12-31 75.03 $6.56 11.44
2021-03-31 107.77 $5.58 19.31
2019-09-30 57.07 $2.59 22.03
2019-06-30 56.26 $0.82 68.61
2019-03-31 54.29 $0.71 76.46
2018-12-31 51.46 $0.79 65.14
2018-09-30 71.63 $3.33 21.51
2018-06-30 69.44 $3.01 23.07
2018-03-31 65.94 $2.13 30.96
2017-12-31 72.25 $3.44 21.00
2017-09-30 59.39 $2.60 22.84
2017-06-30 64.76 $6.50 9.96
2017-03-31 67.97 $6.11 11.12
2016-12-31 64.20 $4.29 14.97
2016-09-30 66.07 $3.46 19.10
2016-06-30 77.32 $1.70 45.48
2016-03-31 73.38 $2.22 33.05
2015-12-31 69.71 $1.23 56.67
2015-09-30 72.33 $2.22 32.58
2015-06-30 79.47 $2.07 38.39
2015-03-31 81.28 $1.97 41.26
2014-12-31 75.74 $3.34 22.68
2014-09-30 73.14 $3.37 21.70
2014-06-30 72.32 $3.16 22.89
2014-03-31 68.85 $3.67 18.79
2013-12-31 63.37 $2.96 21.45
2013-09-30 56.90 $2.72 20.92
2013-06-30 60.40 $2.83 21.34
2013-03-31 59.30 $2.14 27.71
2012-12-31 55.27 $2.73 20.24
2012-09-30 51.81 $2.76 18.80
2012-06-30 49.11 $2.72 18.09
2012-03-31 45.09 $2.74 16.48
2011-12-31 37.91 $2.49 15.25
2011-09-30 31.34 $2.06 15.25
2011-06-30 43.31 $1.92 22.55
2011-03-31 42.76 $1.93 22.21
2010-12-31 34.75 $1.98 17.59
2010-09-30 34.52 $2.16 16.02
2010-06-30 31.22 $2.09 14.94
2009-12-31 29.37 $2.03 14.47
2009-09-30 28.32 $2.02 14.02
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.274B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00